Citadel Advisors’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $318K | Buy |
54,900
+34,000
| +163% | +$225K | ﹤0.01% | 10340 |
|
|
2025
Q4 | $164K | Sell |
20,900
-26,200
| -56% | -$206K | ﹤0.01% | 11213 |
|
|
2025
Q3 | $383K | Buy |
47,100
+800
| +2% | +$5.32K | ﹤0.01% | 9769 |
|
|
2025
Q2 | $216K | Sell |
46,300
-9,500
| -17% | -$43.5K | ﹤0.01% | 10512 |
|
|
2025
Q1 | $306K | Buy |
55,800
+34,100
| +157% | +$138K | ﹤0.01% | 9534 |
|
|
2024
Q4 | $73.6K | Sell |
21,700
-24,000
| -53% | -$77.2K | ﹤0.01% | 11900 |
|
|
2024
Q3 | $130K | Buy |
45,700
+700
| +2% | +$1.8K | ﹤0.01% | 10753 |
|
|
2024
Q2 | $101K | Sell |
45,000
-35,400
| -44% | -$71.3K | ﹤0.01% | 10905 |
|
|
2024
Q1 | $178K | Buy |
80,400
+16,600
| +26% | +$42.9K | ﹤0.01% | 10515 |
|
|
2023
Q4 | $150K | Buy |
63,800
+23,500
| +58% | +$43.4K | ﹤0.01% | 10385 |
|
|
2023
Q3 | $75K | Sell |
40,300
-10,400
| -21% | -$23.8K | ﹤0.01% | 11247 |
|
|
2023
Q2 | $133K | Buy |
50,700
+18,900
| +59% | +$48.1K | ﹤0.01% | 10511 |
|
|
2023
Q1 | $51.8K | Sell |
31,800
-32,600
| -51% | -$40.8K | ﹤0.01% | 12099 |
|
|
2022
Q4 | $85.7K | Buy |
64,400
+20,800
| +48% | +$29.4K | ﹤0.01% | 11432 |
|
|
2022
Q3 | $68K | Sell |
43,600
-2,700
| -6% | -$4.46K | ﹤0.01% | 11412 |
|
|
2022
Q2 | $71K | Buy |
46,300
+400
| +0.9% | +$844 | ﹤0.01% | 11695 |
|
|
2022
Q1 | $118K | Sell |
45,900
-163,100
| -78% | -$398K | ﹤0.01% | 12101 |
|
|
2021
Q4 | $612K | Buy |
209,000
+15,400
| +8% | +$33.3K | ﹤0.01% | 9185 |
|
|
2021
Q3 | $474K | Sell |
193,600
-19,700
| -9% | -$57.2K | ﹤0.01% | 10000 |
|
|
2021
Q2 | $868K | Sell |
213,300
-1,400
| -0.7% | -$5.34K | ﹤0.01% | 8720 |
|
|
2021
Q1 | $968K | Sell |
214,700
-76,800
| -26% | -$414K | ﹤0.01% | 8199 |
|
|
2020
Q4 | $1.43M | Buy |
291,500
+255,000
| +699% | +$1.28M | ﹤0.01% | 6035 |
|
|
2020
Q3 | $216K | Sell |
36,500
-21,000
| -37% | -$84K | ﹤0.01% | 8688 |
|
|
2020
Q2 | $153K | Buy |
57,500
+46,200
| +409% | +$161K | ﹤0.01% | 8733 |
|
|
2020
Q1 | $22K | Buy |
+11,300
| New | +$48.6K | ﹤0.01% | 9279 |
|
Other funds holding XERS
VCM
RA
N
VPM
